TMCnet - World's Largest Communications and Technology Community



Research and Markets: HIV Vaccine Market Opportunity & Clinical Pipeline Analysis
[March 12, 2014]

Research and Markets: HIV Vaccine Market Opportunity & Clinical Pipeline Analysis

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "HIV Vaccine Market Opportunity & Clinical Pipeline Analysis" report to their offering.

Ever since HIV was identified as the cause for AIDS 30 years ago, the HIV virus has become one of the greatest challenges of public health facing all countries of the world. According to UNAIDS, death due to AIDS was estimated to close to 1.6 million in 2012. There were 2.3 million new HIV infections, and about 35.3 million people currently living with HIV.

Given the pace at which the HIV virus is spreading, it is most likely that AIDS would take more lives than ay other infectious disease in the future years to come. In spite of well-expanded programs of prevention and treatment which are currently enabling the stakeholders to address the illness and death associated with HIV and AIDS, the HIV vaccines is considered to be the best solution to end this disease successfully.

HIV/AIDS has become of the leading infectious disease which is taking a huge death toll across the globe, even surpassing TB and malaria. Irrespective of whether the country is developed or developing, the disease is increasingly becoming prevalent, though with serious impact in the developing countries.

Key Topics Covered:

1. Introduction to HIV Vaccine & Mechanism

2. HIV Vaccine: Prevention & Cure

3. Why Need For HIV Vaccines?

4. Global HIV Vaccine Market Outlook

5. Research & Development Funding Scenario for HIV Vaccine

6. HIV Vaccine Market Dynamics

7. FDA Regulatory Framework for Development of HIV Vaccine

8. HIV Vaccine Clinical Trial by Phase & Country

9. Discontinued & Suspended HIV Vaccine Clinical Trial by Phase & Country

10. Competitive Landscape

- Antigen Express

- Bionor Pharma

- FIT Biotech

- GenVec

- GeoVax

- Glaxo Smithkline

- Immune Response BioPharma

- Inovio Pharmaceuticals

- Novartis

- Sanofi Pasteur

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy